Representatives of the Colorado Natural Medicine Division will host five “listening sessions” throughout September and October to engage stakeholders and inform the public of the rollout process of regulated access regulations to the psychedelics legalization ballot measure, reported Marijuana Moment.
Dominique Mendiola, senior director of the division which is under the Department of Revenue, says community involvement is critical in the development of a natural medicine program “that reflects a diversity of perspectives.” The team’s regulatory experience has shown that a key factor is collaborating with all stakeholders.
Mendiola says the listening sessions will “provide a platform for all voices to be heard to ensure the adopted framework is balanced and well-informed.”
Although regulators expect to announce further meetings in the coming months, the events so far scheduled will take place in-person and via Zoom on September 5, 12, 22 and 27, and October 3.
Topics to be discussed include SB 23-290's overview and an intro to the Natural Medicine Division; first and multi-responder training; public education campaigns; testing program; and cultivation and manufacturing practices concerning the legal therapeutic provision of psilocybin and psilocin, and potentially ibogaine, mescaline (not derived from peyote) and DMT.
The meetings will be recorded and open to the public, but in-person attendance is yet to be determined by available space at the Department of Revenue.
Additionally, the 15-member Natural Medicine Advisory Board will also host several meetings throughout Sept. 25.
The news is timely considering that, since Prop. 122’s passing, Colorado has seen the flourishing of a gray market for psilocybin that includes not only the sale of psychedelic-containing products but also tripsitting and therapeutic services (see NPR’s July report with state Senate president Steve Fenberg’s concerns).
If you're following the cannabis industry, our upcoming Cannabis Capital Conference is where you ought to be. Whether to close your deals or just get acquainted with the sector’s best, come join us on Sept. 27-28 in Chicago for our 17th edition! Tickets HERE.
Photo: Benzinga edit with photo by Serrgey75, rybart and fizkes on Shutterstock.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.